Meghraj Suryawanshi | Pharmacology and Pharmaceutical Science | Best Researcher Award

Published on by World Top Scientists

Prof. Dr. Meghraj Suryawanshi | Pharmacology and Pharmaceutical Science | Best Researcher Award

Assistant Professor | Sandip Institute of Pharmaceutical Sciences | India

Dr. Meghraj Vivekanand Suryawanshi is an accomplished Associate Professor and Training & Placement Coordinator at the Sandip Institute of Pharmaceutical Sciences, Nashik, specializing in pharmaceutics. He holds a Ph.D. in Pharmaceutics from Jaipur National University, an M.Pharm in Pharmaceutics from R.C. Patel Institute of Pharmaceutical Education and Research, a B.Pharm from Sinhgad Institutes of Pharmaceutical Sciences, and an MBA in Hospital Administration. Dr. Suryawanshi has extensive professional experience, serving as a Ph.D. research scholar, Assistant Professor at multiple institutions, and co-founder and CTO of AllWell Nutritech LLP, where he contributed to start-up incubation and entrepreneurial initiatives. He has supervised numerous undergraduate and postgraduate students and actively coordinated academic and administrative programs including training and placement, entrepreneurship, library management, and examination coordination. His research focuses on advanced drug delivery systems, formulation development, and pharmaceutical technology, with a significant body of publications contributing to national and international journals. Dr. Suryawanshi has also engaged in editorial responsibilities and professional memberships that support scholarly exchange and innovation in the pharmaceutical sciences. Recognized for his dedication to research, education, and mentorship, he has been instrumental in fostering academic excellence, student development, and industry collaboration, demonstrating leadership, scientific rigor, and a commitment to advancing the field of pharmaceutics at both institutional and broader professional levels.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Suryawanshi, I., Srinidhi, S., Singh, S., Kalia, R., Kunchala, R. K., Mudavath, S. L., …. (2021). Downshifting and upconversion dual mode emission from lanthanide doped GdPO4 nanorods for unclonable anti-counterfeiting. Materials Today Communications, 26, 102144.

2. Patil, S. M., Suryawanshi, M. V., Chandanshive, V. V., Kurade, M. B., Govindwar, S. P., …. (2020). Regeneration of textile wastewater deteriorated microbial diversity of soil microcosm through bioaugmentation. Chemical Engineering Journal, 380, 122533.

3. Suryawanshi, M. V., Gujarathi, P. P., Mulla, T., & Bagban, I. (2024). Hypericum perforatum: A comprehensive review on pharmacognosy, preclinical studies, putative molecular mechanism, and clinical studies in neurodegenerative disorders. Naunyn-Schmiedeberg’s Archives of Pharmacology, 397(6), 3803–3818.

4. Bhagat, D. S., Suryawanshi, I. V., Gurnule, W. B., Sawant, S. S., & Chavan, P. B. (2021). Greener synthesis of CuO nanoparticles for enhanced development of latent fingerprints. Materials Today: Proceedings, 36, 747–750.

5. Suryawanshi, I., Kalia, R., Kunchala, R. K., Mudavath, S. L., & Naidu, B. S. (2022). Detection of latent fingerprints using luminescent Gd0.95Eu0.05PO4 nanorods. Journal of Rare Earths, 40(4), 572–578.

Angelica Rachel Carpio | Pharmacology | Best Researcher Award

Published on by World Top Scientists

Ms. Angelica Rachel Carpio | Pharmacology | Best Researcher Award

Ms. Angelica Rachel Carpio at DLSU Laguna, Philippines

Angelica Rachel E. Carpio is a highly driven bioengineer and nanotechnology researcher from Mapúa University, where she is completing both her Bachelor’s and Master’s degrees in Biological Engineering. With published research in respected journals such as Life and the Journal of the Taiwan Institute of Chemical Engineers, her work explores innovative applications of natural compounds and nanomaterials for therapeutic use. She has hands-on experience in advanced laboratory techniques, computational modeling, and scientific writing, strengthened by international research training in Taiwan and immersion in Japan. Currently, she contributes to nanotechnology development at De La Salle University, focusing on photoluminescent inks using carbon nanodots. In addition to her technical expertise, Angelica has held leadership roles in various academic organizations, showcasing her teamwork and communication skills. Her multidisciplinary approach, academic excellence, and commitment to scientific advancement make her a promising and impactful researcher in the field of bioengineering and nanotechnology.

Professional Profile 

Scopus Profile

Education

Angelica Rachel E. Carpio is currently pursuing a dual degree program—Bachelor and Master of Science in Biological Engineering—at Mapúa University in Manila, Philippines, from 2020 to 2025. Her academic journey reflects consistent excellence, having previously completed the Science, Technology, Engineering, and Mathematics (STEM) strand during her senior high school years at the same university. Throughout her education, Angelica has been recognized for her academic performance, earning quarterly and semestral honors. Her foundational years at St. Mary’s Academy of Caloocan City also demonstrate early academic strength. Her coursework blends bioengineering, nanotechnology, and computational sciences, preparing her for interdisciplinary research. Her involvement in technical and laboratory-intensive education has equipped her with both theoretical knowledge and practical skills, making her a well-rounded scholar capable of tackling complex scientific challenges across engineering and life sciences.

Professional Experience

Angelica Rachel E. Carpio has gained practical research and academic experience in multiple capacities across institutions. As of March 2025, she serves as a Project Technical Assistant I at De La Salle University’s Center for Natural Sciences and Environmental Research, where she is actively involved in nanotechnology research, particularly the development of photoluminescent inks using carbon nanodots. Previously, she completed a research internship at National I-lan University in Taiwan, contributing to projects in biochemistry and microbial fuel cells, which culminated in a scholarly publication. Her earlier experience includes a role as a Student Assistant at Mapúa University, where she facilitated administrative tasks and student outreach. She also participated in a scientific immersion program in Tokyo, Japan, expanding her global perspective. These diverse roles reflect a well-rounded professional background that combines scientific inquiry, technical execution, and organizational support, laying a strong foundation for a research-intensive career.

Research Interest

Angelica’s research interests are rooted in the intersection of bioengineering, nanotechnology, and computational biology. She focuses on developing therapeutic strategies using natural products, such as plant metabolites and microbial fermentation, combined with modern molecular techniques. Her recent publications explore the anti-cancer potential of Vaccinium-derived compounds and the enhanced production of anthraquinones in rhubarb through fermentation, showcasing her inclination toward pharmacological innovation using bioinformatics tools like molecular docking and network analysis. She is also engaged in nanomaterial research, particularly in developing carbon-based nanodots for photoluminescent applications, revealing a keen interest in functional biomaterials. Her ability to integrate wet-lab experiments with computational modeling highlights a strong systems-level approach to research. This multidimensional interest positions her at the forefront of modern biological engineering, where she aims to bridge natural sciences with engineered solutions for health and environmental applications.

Award and Honor

Angelica Rachel Carpio has consistently earned recognition for her academic and leadership excellence throughout her educational journey. She has received quarterly and semestral academic excellence awards during her time in senior high school at Mapúa University, where she graduated with honors. At St. Mary’s Academy of Caloocan City, she was also an Academic Excellence Awardee, underscoring her consistent performance from an early age. While specific research awards are not listed, her publications in reputable international journals, her international research internship in Taiwan, and participation in a scientific immersion in Japan stand as strong indicators of merit. Furthermore, her selection as a Project Technical Assistant I at a prominent research center such as De La Salle University is, in itself, a form of professional recognition. These accomplishments reflect both academic rigor and early research impact, validating her potential as a high-achieving scholar and future leader in scientific research.

Conclusion

Angelica Rachel E. Carpio emerges as a promising and multifaceted researcher with a solid educational background, hands-on professional experience, and a clear focus on innovation at the intersection of nanotechnology and biological engineering. Her early contributions to research through published work, international exposure, and technical roles at prestigious institutions showcase her ability to apply scientific knowledge to real-world problems. Angelica’s diverse skill set—from laboratory techniques and computational modeling to leadership in academic organizations—demonstrates maturity beyond her years. She represents the new generation of researchers who are collaborative, globally aware, and technically adept. With continued mentorship and opportunities to expand her research portfolio, Angelica is well on track to make meaningful contributions to the scientific community. Her credentials make her an excellent candidate for honors such as the Best Researcher Award, especially in the category of emerging or early-career researchers.

Publications Top Notes

  • Title: Berries as Nature’s Therapeutics: Exploring the Potential of Vaccinium Metabolites in Gastric Cancer Treatment Through Computational Insights
    Authors: Carpio, Angelica Rachel; Talubo, Nicholas Dale D.; Tsai, Po Wei; Chen, Boryann; Tayo, Lemmuel Lara
    Year: 2025
    Journal: Life

Marta C Monteiro | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by World Top Scientists

Prof. Dr. Marta C Monteiro | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Professora Associada at Universidade Federal do Pará, Brazil

Dr. Marta Chagas Monteiro is a distinguished biomedical researcher specializing in microbiology, immunology, and pharmacology. She holds a CNPq 1D Productivity Scholarship and serves as a professor and research coordinator at the Federal University of Pará (UFPA), Brazil. With over two decades of experience, she has made significant contributions to understanding infectious diseases, immune responses, and drug development. Her collaborations span international institutions, including the University of São Paulo, Aston University, and the University of Shanghai. As a prolific researcher, she has authored over 100 high-impact publications and serves on the editorial boards of leading scientific journals. Dr. Monteiro is also an active mentor, shaping future scientists through postgraduate programs. Her expertise in oxidative stress, biomarkers, and xenobiotic toxicity has positioned her as a leading figure in biomedical research, earning her recognition from national and international funding agencies.

Professional Profile

Education

Dr. Monteiro earned her Ph.D. in Basic and Applied Immunology from the University of São Paulo in 2004, focusing on immune responses and cellular migration in infectious diseases. Prior to that, she completed her Master’s degree in the same field at USP in 2000, with research centered on parasitology and pharmacology. Her academic foundation was laid at the Federal University of Pará, where she obtained a bachelor’s degree in Medical Biology in 1997. Over the years, she has pursued numerous specialized training courses in pharmacology, immunology, and biomedicine, including programs on oxidative stress, epigenetics, and experimental pharmacology. Her continuous education reflects a commitment to interdisciplinary research, integrating immunopharmacology, microbiology, and biotechnology into her work. This extensive academic background has enabled her to make significant contributions to scientific advancements, particularly in the study of immune responses, biomarkers, and the pharmacological effects of drugs on infectious and neurodegenerative diseases.

Professional Experience

Dr. Monteiro is a professor and coordinator at the Faculty of Pharmacy at UFPA, where she leads the Laboratory of Oxidative Stress and Clinical Immunology. She is actively involved in postgraduate programs in pharmaceutical sciences, neuroscience, and pharmacology. Beyond academia, she serves as an expert evaluator for major funding organizations, including CNPq, SUS, and INEP. Her work also extends to international collaborations, with ongoing projects in partnership with institutions in Brazil, the UK, and China. Additionally, she is a consultant for over 15 research development agencies and a reviewer for more than 90 scientific journals. As part of her professional engagements, she has contributed to the development of new pharmacological treatments, diagnostic tools, and innovative technologies in immunology. Her leadership in academia and research has significantly impacted biomedical advancements, particularly in the areas of infectious disease management and pharmacological interventions.

Research Interests

Dr. Monteiro’s research focuses on microbiology, clinical immunology, and pharmacology, with a particular emphasis on biomarkers and immune responses in infectious diseases. She investigates the pharmacological activities of drugs and natural products, as well as their toxicological effects on human health. Her work extends to studying oxidative stress, inflammation, and xenobiotic-mediated toxicity, providing insights into the development of new therapeutic strategies. Additionally, she explores neurodegenerative, autoimmune, and parasitic diseases, including malaria, tuberculosis, leishmaniasis, and sepsis. Through her extensive research, she has contributed to advancements in immunopharmacology, helping to identify novel drug targets and therapeutic interventions. Her multidisciplinary approach, combining molecular biology, pharmacology, and biotechnology, has led to breakthroughs in disease diagnostics and treatment methodologies, further solidifying her reputation as a leading expert in biomedical sciences.

Awards and Honors

Dr. Monteiro has received numerous accolades in recognition of her contributions to biomedical research. She is a recipient of the prestigious CNPq 1D Productivity Scholarship, which highlights her excellence in scientific investigation. Her research has been funded by national and international agencies, reflecting the high impact of her work. She has also been recognized for her role as an editor and reviewer for top-tier journals, including Frontiers in Immunology and Oxidative Medicine and Cellular Longevity. Additionally, she has contributed to the scientific community as a consultant and evaluator for research projects funded by leading organizations. Her patents and published innovations in immunopharmacology and microbiology have further established her as a respected figure in the field. Through her dedication to research, teaching, and mentorship, she has made a lasting impact on the scientific landscape, earning widespread recognition for her contributions to global health and biomedical advancements.

Conclusion

Dr. Marta Chagas Monteiro is highly qualified for the Best Researcher Award due to her extensive contributions, leadership in microbiology and immunology, international collaborations, and significant research impact. Strengthening her translational research and public engagement could further enhance her profile, but overall, she is a strong candidate.

Publications Top Notes

  1. Monteiro, M.C., Quadros Gomes, B.A., Dos Santos, S.M., Gato, L.D.S., Coleman, M.D. (2025)

    • Alpha-Lipoic Acid Reduces Neuroinflammation and Oxidative Stress Induced by Dapsone in an Animal Model.

    • Journal: Nutrients

    • Citations: 0

  2. Monteiro, M.C., de Farias, E.C.F., Pavão Júnior, M.J.C., de Sales, S.C.D., Terreri, M.T.R.A. (2024)

    • Factors associated with mortality in children with critical COVID-19 and multisystem inflammatory syndrome in a resource-poor setting.

    • Journal: Scientific Reports

    • Citations: 2

  3. Monteiro, M.C. (co-author), Dos Santos, É.R.Q., Pantoja, L.V.P.D.S., Farias, S.V., Maia, J.G.S., Maia, C.S. (2024)

    • Linalool-rich rosewood essential oil (Aniba rosaeodora Ducke) mitigates emotional and neurochemical impairments induced by ethanol binge-like exposure during adolescence in female rats.

    • Journal: Biomedicine and Pharmacotherapy

    • Citations: 0

  4. Monteiro, M.C., Navegantes-Lima, K.C., Gaspar, S.L.D.F., De, A.L., Sovrani, V. (2024)

    • Lipid Fraction from Agaricus brasiliensis as a Potential Therapeutic Agent for Lethal Sepsis in Mice.

    • Journal: Antioxidants

    • Citations: 0

  5. Monteiro, M.C. (co-author), de Farias, E.C.F., Nascimento, L.M.P.P., Pavão Júnior, M.J.C., Clemente, G., Terreri, M.T.R.A. (2024)

    • Plasma IL-17A is increased in patients with critical MIS-C and associated with in-hospital mortality.

    • Journal: Frontiers in Immunology

    • Citations: 0

  6. Monteiro, M.C., Matos-Sousa, J.M., Chemelo, V.S., Frazão, D.R., Lima, R.R. (2024)

    • Is there any association between the presence of biomarkers and apical periodontitis? A systematic review.

    • Journal: [No source information available]

    • Citations: 3

  7. Monteiro, M.C., Valois, F.P., Bezerra, K.C.A., da Costa Assunção, F.P., Machado, N.T. (2024)

    • Improving the Antioxidant Activity, Yield, and Hydrocarbon Content of Bio-Oil from the Pyrolysis of Açaí Seeds by Chemical Activation: Effect of Temperature and Molarity.

    • Journal: Catalysts

    • Citations: 1

  8. Monteiro, M.C., Meneses, C.C.F., de Sousa, P.R.M., Lima, K.C.N., Lameira, J. (2023)

    • Caffeic Acid-Zinc Basic Salt/Chitosan Nanohybrid Possesses Controlled Release Properties and Exhibits In Vivo Anti-Inflammatory Activities.

    • Journal: Molecules

    • Citations: 3

  9. Monteiro, M.C. (co-author), Camara, F.M.S., da Conceição, B.C., Cardoso, E.K.S., Maia, C.S., Fontes-Júnior, E.A. (2023)

    • Margaritaria nobilis L.f. (Phyllanthaceae) Ethanolic Extract: Low Acute Oral Toxicity and Antinociceptive Activity.

    • Journal: Pharmaceuticals

    • Citations: 1

  10. Monteiro, M.C. (co-author), Dorneles, G.P., Teixeira, P.C., Peres, A.L., Wendland, E.M., Romão, P.R.T. (2023)

  • Endotoxin tolerance and low activation of TLR-4/NF-κB axis in monocytes of COVID-19 patients.

  • Journal: Journal of Molecular Medicine

  • Citations: 8

 

Dania Alhyari | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by World Top Scientists

Assist. Prof. Dr. Dania Alhyari | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Assistant Professor at Petra University, Jordan

Dr. Dania Alhyari is an accomplished pharmaceutical sciences researcher and assistant professor with over a decade of experience in academia, research, and mentorship. Her expertise lies in drug formulation, permeability, solubility, and phytochemistry, with a strong focus on enhancing drug bioavailability and therapeutic efficacy. She earned her Ph.D. in Pharmaceutical Sciences from the University of Bradford, UK, and a Master’s in Molecular Biology from the University of Ottawa, Canada. Throughout her career, she has been actively involved in teaching and research, currently serving as an Assistant Professor at Petra University, Jordan, where she mentors graduate students and leads research projects on novel drug delivery systems. Previously, she was a Postdoctoral Fellow at the University of Bradford, where she collaborated on interdisciplinary research and presented findings at international conferences. Dr. Alhyari has published extensively in reputed journals, contributing to advancements in pharmaceutical sciences. Her work emphasizes the integration of molecular biology with drug formulation to optimize therapeutic outcomes. She has also received recognition for her academic contributions, including invitations to speak at conferences and research grants for her studies. With a strong background in teaching, research, and international collaboration, Dr. Alhyari continues to make significant contributions to pharmaceutical innovation.

Professional Profile

Education

Dr. Dania Alhyari holds a strong academic background in pharmaceutical sciences and molecular biology, which has shaped her expertise in drug formulation and biopharmaceutical research. She earned her Ph.D. in Pharmaceutical Sciences from the University of Bradford, UK, where she focused on drug permeability and solubility studies, developing innovative methodologies to enhance drug bioavailability. Her doctoral research involved interdisciplinary collaborations and was presented at several international conferences. Prior to her Ph.D., she completed a Master’s degree in Molecular Biology at the University of Ottawa, Canada, where she gained in-depth knowledge of biochemical and genetic interactions related to pharmaceutical applications. During her master’s studies, she engaged in extensive laboratory work, investigating drug interactions at the molecular level. Her academic journey began with a Bachelor’s degree in Pharmacy, where she developed a solid foundation in drug formulation, pharmacokinetics, and analytical techniques. Throughout her education, Dr. Alhyari actively participated in research projects, contributing to publications and advancing pharmaceutical knowledge. Her diverse educational background, spanning pharmacy, molecular biology, and pharmaceutical sciences, has provided her with a multidisciplinary perspective that enhances her research capabilities. With a commitment to scientific discovery, her education has been instrumental in shaping her career in academia and pharmaceutical research.

Professional Experience

Dr. Dania Alhyari has amassed extensive professional experience in pharmaceutical research and academia, contributing significantly to drug formulation, solubility, and permeability studies. She currently serves as an Assistant Professor at Petra University, Jordan, where she teaches advanced courses in pharmaceutics and pharmaceutical technology while mentoring graduate students in innovative drug delivery research. In this role, she leads research projects exploring novel drug formulations and collaborates with international experts to enhance pharmaceutical applications. Prior to this, she worked as a Postdoctoral Fellow at the University of Bradford, UK, where she developed cutting-edge methodologies for drug permeability and solubility studies. During her postdoctoral tenure, she mentored students, presented her findings at international conferences, and worked closely with interdisciplinary teams to advance pharmaceutical research. Earlier in her career, Dr. Alhyari served as a Research and Teaching Assistant at Petra University, where she played a key role in curriculum development, laboratory research, and student mentorship. She co-authored multiple research papers and contributed to the design of laboratory experiments that enhanced the university’s pharmaceutical research capabilities. Her professional journey reflects a strong balance between research, teaching, and leadership, positioning her as a key contributor to the advancement of pharmaceutical sciences and education.

Research interest

Dr. Dania Alhyari’s research interests lie at the intersection of drug formulation, permeability, solubility, and phytochemistry, with a focus on optimizing drug delivery systems for improved therapeutic outcomes. She is particularly interested in enhancing the bioavailability of pharmaceutical compounds by studying their physicochemical and biopharmaceutical properties. Her work explores innovative drug delivery mechanisms, including novel excipients, nanoformulations, and targeted drug transport to improve drug absorption and efficacy. Additionally, she investigates the role of natural compounds in pharmaceutical sciences, studying their antioxidant, anti-inflammatory, and bioavailability-enhancing properties. Through interdisciplinary collaborations, she integrates molecular biology techniques with pharmaceutical sciences to better understand drug interactions at the cellular and molecular levels. Dr. Alhyari is also passionate about the development of more efficient and patient-friendly pharmaceutical formulations, ensuring safer and more effective therapeutic interventions. Her research extends to the evaluation of drug-excipient interactions, solubility enhancement strategies, and the design of pharmaceutical formulations that cater to specific medical needs. By combining experimental research with advanced analytical techniques, she aims to contribute to the evolution of drug development and pharmaceutical innovation. Her research efforts have been recognized through publications in high-impact journals and presentations at international conferences.

Award & Honor

Dr. Dania Alhyari has received several awards and honors in recognition of her outstanding contributions to pharmaceutical sciences, research, and education. Her dedication to advancing drug formulation and delivery systems has earned her invitations to present her findings at prestigious international conferences, where she has been acknowledged for her innovative research. She has also secured research grants that have supported her studies in drug permeability, solubility enhancement, and pharmaceutical applications, further demonstrating the significance of her work. Throughout her academic career, she has been recognized for excellence in teaching and mentorship, guiding both undergraduate and graduate students in pharmaceutical research. Her contributions to scientific literature, including publications in high-impact journals, have been widely cited, highlighting the relevance of her research in the global pharmaceutical community. Additionally, she has collaborated with leading researchers from renowned institutions in the UK and Canada, receiving commendations for her interdisciplinary work in pharmaceutical sciences and molecular biology. Dr. Alhyari’s commitment to research excellence, innovation, and education continues to be acknowledged through various accolades, reinforcing her position as a leading researcher in her field. Her achievements reflect her dedication to pushing the boundaries of pharmaceutical research and inspiring future scientists.

Conclusion

Dania Alhyari is a strong candidate for the Best Researcher Award due to her research output, international collaborations, and academic contributions. However, strengthening aspects like grant funding, patents, and research impact metrics would further solidify her case.

Publications Top Notes

  • Physicochemical and biopharmaceutical characterization of new sulfonamide derivatives of gallic acid

    • Author(s): D. Alhyari, H. Sheldrake, S. Kantamneni, M. Isreb, S.J. Soumehsaraei, et al.

    • Year: 2022

    • Citations: 4

  • Antioxidant, Anti-Inflammatory, and Oral Bioavailability of Novel Sulfonamide Derivatives of Gallic Acid

    • Author(s): D. Alhyari, N.A. Qinna, H.M. Sheldrake, S. Kantamneni, B.Y. Ghanem, et al.

    • Year: 2025

    • Citations: Not available yet (recent publication)

  • Physicochemical and biopharmaceutical characterization of novel derivatives of gallic acid

    • Author(s): D.H. Alhyari

    • Year: 2022

    • Citations: Not available (Thesis/Dissertation)

 

Nceba Gqaleni | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by World Top Scientists

Prof. Nceba Gqaleni | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Research Professor at University of KwaZulu-Natal, South Africa

Professor Nceba Gqaleni is a renowned academic and researcher at the University of KwaZulu-Natal, South Africa. He currently serves as an Acting Academic Leader in the Discipline of Traditional Medicine and as a Research Professor. With a passion for integrating traditional medicine into mainstream healthcare, his research aims to address health challenges facing Africa, including HIV, diabetes, and cancer. His work on herbal treatments and immunomodulators has positioned him as a pioneer in exploring alternative therapies. Prof. Gqaleni’s research is characterized by the synergy between modern science and indigenous knowledge systems, contributing significantly to the global healthcare landscape. His work continues to impact public health, with ongoing clinical trials and innovative studies aimed at improving health outcomes. Additionally, he is committed to training the next generation of researchers, having mentored numerous postdoctoral, PhD, and master’s students.

Professional Profile

Education

Professor Nceba Gqaleni’s educational background is rooted in biochemistry, with a PhD in Biochemistry from the University of Strathclyde in Glasgow, UK. He also holds a Master’s degree in Biochemistry from the University of KwaZulu-Natal (UKZN), South Africa. His academic journey has been marked by a deep interest in both the molecular and traditional aspects of medicine, leading him to pursue research that bridges these fields. His formal education laid the foundation for a distinguished career in both academia and research, where he has applied his scientific expertise to explore alternative therapies and the integration of traditional medicine into contemporary health systems. Prof. Gqaleni’s educational path reflects a commitment to advancing knowledge and improving healthcare, particularly in the African context.

Professional Experience

Professor Gqaleni’s professional experience spans academia, research, and leadership. He currently holds the position of Acting Academic Leader in the Discipline of Traditional Medicine at the University of KwaZulu-Natal. His role involves guiding academic initiatives and research in traditional medicine, while also providing leadership in curriculum development and research supervision. In addition to his academic responsibilities, Prof. Gqaleni has led numerous significant research projects, particularly focused on traditional medicine’s role in addressing major health issues such as HIV and diabetes. His extensive work in supervising postgraduate students, including over 7 postdoctoral researchers, 12 PhD candidates, and 25 master’s students, demonstrates his dedication to nurturing the next generation of scholars and researchers. Prof. Gqaleni’s professional experience is a blend of academic excellence, mentorship, and groundbreaking research in the field of traditional medicine and biochemistry.

Research Interests

Professor Nceba Gqaleni’s research interests lie at the intersection of biochemistry and traditional medicine, with a primary focus on finding alternative treatments for diseases prevalent in Africa, such as HIV, diabetes, and cancer. He has led pioneering research on herbal compositions for the treatment of HIV and is currently conducting clinical trials for a patented HIV cure. In addition to HIV, his research extends to cancer therapies, immunomodulators, and the application of Indigenous phytotherapy in managing diseases like diabetes and HIV. Prof. Gqaleni’s ongoing research projects also explore the health and wellness of Indigenous peoples, particularly in the context of climate change and global health disparities. His work is driven by the goal of bridging the gap between traditional healing practices and modern medical approaches, thereby improving health outcomes in African communities and globally.

Awards and Honors

Professor Nceba Gqaleni’s career has been marked by significant achievements and recognition. He has been honored for his pioneering work in traditional medicine and biochemistry, particularly in the field of HIV and diabetes treatment. One of his notable accomplishments is the filing of a patent for a herbal composition aimed at curing HIV, which is currently undergoing clinical trials. Prof. Gqaleni has also received substantial funding for his research, including a $4.4 million NIH grant for a study on Indigenous phytotherapy. His contributions to science and public health have earned him the respect of both academic and medical communities. Prof. Gqaleni’s work in advancing the integration of traditional medicine into global health systems continues to garner international attention and recognition. His awards and honors reflect his exceptional leadership and groundbreaking contributions to healthcare research.

Conclusion

Professor Nceba Gqaleni demonstrates exceptional potential for the Best Researcher Award due to his innovative contributions to HIV treatment, integration of traditional medicine, and impactful mentorship. His work addresses critical health challenges in Africa, blending traditional knowledge with modern scientific methods. While broader dissemination and commercialization efforts could strengthen his profile, his contributions make him a strong contender for the award.

Publications Top Noted

  • Indigenous Medicinal Plants Used in the Management of Diabetes in Africa: 5 Years (2019–2024) in Perspective
    • Authors: Frimpong, E.K., Thembane, N., Hlatshwayo, S., Ngcobo, M., Gqaleni, N.
    • Year: 2024
    • Citations: 2
  • Review on the Anti-Hyperglycemic Potential of Psidium guajava and Seriphium plumosum L.
    • Authors: Thembane, N., Hlatshwayo, S., Ngcobo, M., Ngubane, P., Gqaleni, N.
    • Year: 2024
    • Citations: 1
  • Erratum: An in vitro study to elucidate the effects of Product Nkabinde on immune response in peripheral blood mononuclear cells of healthy donors
    • Authors: Setlhare, B., Letsoalo, M., Nkabinde, S.A., Ngcobo, M., Gqaleni, N.
    • Year: 2024
    • Citations: 0
  • An in vitro study to elucidate the effects of product Nkabinde on immune response in peripheral blood mononuclear cells of healthy donors
    • Authors: Setlhare, B., Letsoalo, M., Nkabinde, S.A., Ngcobo, M., Gqaleni, N.
    • Year: 2024
    • Citations: 1
  • Analysis of Three Species of Cassipourea Traditionally Used for Hypermelanosis in Selected Provinces in South Africa
    • Authors: Mpofana, N., Yalo, M., Gqaleni, N., Dlova, N.C., Hussein, A.A.
    • Year: 2024
    • Citations: 0
  • Melasma in People with Darker Skin Types: A Scoping Review Protocol on Prevalence, Treatment Options for Melasma, and Impact on Quality of Life
    • Authors: Mpofana, N., Chibi, B., Gqaleni, N., Kgarosi, K., Dlova, N.C.
    • Year: 2023
    • Citations: 3
  • The Effect of Melasma on the Quality of Life in People with Darker Skin Types Living in Durban, South Africa
    • Authors: Mpofana, N., Paulse, M., Gqaleni, N., Hussein, A., Dlova, N.C.
    • Year: 2023
    • Citations: 0
  • The Met and Unmet Health Needs for HIV, Hypertension, and Diabetes in Rural KwaZulu-Natal, South Africa: Analysis of a Cross-Sectional Multimorbidity Survey
    • Authors: Singh, U., Olivier, S., Cuadros, D., Ramnanan, A., Harilall, S., Gqaleni, N.
    • Year: 2023
    • Citations: 5
  • An Investigation into the Acute and Subacute Toxicity of Extracts of Cassipourea flanaganii Stem Bark In Vivo
    • Authors: Mpofana, N., Chipangura, J.K., Paulse, M., Hussein, A.A., Crouch, N.R.
    • Year: 2023
    • Citations: 2
  • Treatment of Melasma on Darker Skin Types: A Scoping Review
    • Authors: Mpofana, N., Chibi, B., Visser, T., Hussein, A.A., Dlova, N.C.
    • Year: 2023
    • Citations: 4